End-of-day quote
Korea S.E.
23:00:00 30/05/2024 BST
|
5-day change
|
1st Jan Change
|
347
KRW
|
+0.58%
|
|
-0.29%
|
-18.74%
|
04-24 |
EQ Maxon Pharmaceutical Co., Ltd., LAT Co.,Ltd. and Yeju Industrial Co. Ltd. cancelled the acquisition of 30.9% stake in Zinitix Co., Ltd. from Seoul Electronics & Telecom Co., Ltd, Wonwoo Kim and Sua Kim
|
CI
| 04-12 |
LAT Co.,Ltd. and Yeju Industrial Co. Ltd. cancelled the acquisition of 30.9% stake in Zinitix Co., Ltd. from Seoul Electronics & Telecom Co., Ltd, Wonwoo Kim and Sua Kim.
|
CI
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
75,450
|
70,284
|
59,846
|
53,235
|
41,683
|
29,714
|
Enterprise Value (EV)
1 |
94,787
|
87,649
|
76,053
|
81,402
|
72,252
|
61,292
|
P/E ratio
|
-18.1
x
|
17.2
x
|
-17.7
x
|
910
x
|
-4.02
x
|
-2.04
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.89
x
|
1.07
x
|
1
x
|
0.77
x
|
0.8
x
|
0.86
x
|
EV / Revenue
|
1.12
x
|
1.34
x
|
1.27
x
|
1.18
x
|
1.39
x
|
1.77
x
|
EV / EBITDA
|
308
x
|
148
x
|
67.4
x
|
32
x
|
-12.9
x
|
-36.9
x
|
EV / FCF
|
41.5
x
|
-16.9
x
|
21.1
x
|
-24.8
x
|
47.1
x
|
4.61
x
|
FCF Yield
|
2.41%
|
-5.92%
|
4.73%
|
-4.03%
|
2.12%
|
21.7%
|
Price to Book
|
2.21
x
|
0.75
x
|
0.54
x
|
0.59
x
|
0.77
x
|
0.76
x
|
Nbr of stocks (in thousands)
|
64,764
|
69,588
|
69,588
|
69,588
|
69,588
|
69,588
|
Reference price
2 |
1,165
|
1,010
|
860.0
|
765.0
|
599.0
|
427.0
|
Announcement Date
|
18/03/19
|
16/03/20
|
18/03/21
|
23/03/22
|
23/03/23
|
21/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
84,618
|
65,589
|
59,824
|
69,119
|
51,836
|
34,587
|
EBITDA
1 |
307.9
|
590.6
|
1,128
|
2,542
|
-5,613
|
-1,663
|
EBIT
1 |
-1,691
|
-1,832
|
-1,680
|
-118.6
|
-7,727
|
-3,757
|
Operating Margin
|
-2%
|
-2.79%
|
-2.81%
|
-0.17%
|
-14.91%
|
-10.86%
|
Earnings before Tax (EBT)
1 |
-4,589
|
64.18
|
-3,494
|
884.2
|
-11,298
|
-14,796
|
Net income
1 |
-4,179
|
4,051
|
-3,373
|
58.5
|
-10,364
|
-14,549
|
Net margin
|
-4.94%
|
6.18%
|
-5.64%
|
0.08%
|
-19.99%
|
-42.07%
|
EPS
2 |
-64.53
|
58.56
|
-48.46
|
0.8406
|
-148.9
|
-209.1
|
Free Cash Flow
1 |
2,285
|
-5,187
|
3,600
|
-3,281
|
1,535
|
13,305
|
FCF margin
|
2.7%
|
-7.91%
|
6.02%
|
-4.75%
|
2.96%
|
38.47%
|
FCF Conversion (EBITDA)
|
742.07%
|
-
|
319.24%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
18/03/19
|
16/03/20
|
18/03/21
|
23/03/22
|
23/03/23
|
21/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
19,338
|
17,365
|
16,207
|
28,167
|
30,568
|
31,578
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
62.81
x
|
29.4
x
|
14.37
x
|
11.08
x
|
-5.446
x
|
-18.99
x
|
Free Cash Flow
1 |
2,285
|
-5,187
|
3,600
|
-3,281
|
1,535
|
13,305
|
ROE (net income / shareholders' equity)
|
-11.7%
|
6.35%
|
-3.31%
|
0.06%
|
-14.4%
|
-31.2%
|
ROA (Net income/ Total Assets)
|
-1.35%
|
-1.05%
|
-0.7%
|
-0.05%
|
-3.44%
|
-1.96%
|
Assets
1 |
308,887
|
-386,095
|
478,860
|
-123,412
|
301,620
|
744,154
|
Book Value Per Share
2 |
526.0
|
1,343
|
1,588
|
1,295
|
780.0
|
559.0
|
Cash Flow per Share
2 |
97.10
|
46.40
|
85.30
|
121.0
|
258.0
|
220.0
|
Capex
1 |
641
|
3,132
|
171
|
1,736
|
6,130
|
1,086
|
Capex / Sales
|
0.76%
|
4.77%
|
0.29%
|
2.51%
|
11.82%
|
3.14%
|
Announcement Date
|
18/03/19
|
16/03/20
|
18/03/21
|
23/03/22
|
23/03/23
|
21/03/24
|
|
1st Jan change
|
Capi.
|
---|
| -18.74% | 17.46M | | +6.55% | 45.84B | | +197.28% | 5.66B | | -7.44% | 2.66B | | -8.20% | 2.64B | | +121.61% | 1.4B | | -28.92% | 1.14B | | -8.76% | 994M | | +40.02% | 894M | | +15.88% | 1.05B |
Electrical Component
|